Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to evaluate the influence of metformin on lactate metabolism.

The main outcome is the lactate production following an exogenous lactate overload in healthy male subjects without metformin and one week later with metformin.


Clinical Trial Description

Study design: Physiological study, controlled, open, non randomised

Healthy male subjects, 18 to 30 years old

Principal objective : To evaluate the influence of metformin on lactate metabolism (production) following exogenous lactate overload.

- Objective 2: To evaluate the influence of metformin on lactate metabolism (production) after muscular exercise.

- Objective 3: To evaluate the influence of metformin on lactate metabolism (elimination) after exogenous lactate overload.

- Objective 4: To evaluate the influence of metformin on lactate metabolism (elimination) after muscular exercise.

Principal outcome : Lactate production following exogenous lactate overload.

- Outcome 2: Production of lactate following muscular exercise test.

- Outcome 3 and 3': Parameters modelizing elimination of lactate following exogenous lactate overload (bi-exponential model).

- Outcome 4 and 4': Parameters modelizing elimination of lactate following muscular exercise test (bi-exponential model).

Inclusion criteria:

- Healthy male subjects, 18 to 30 years

- Body mass index (BMI) between 21 and 25 kg/m2 inclusive

- Informed consent

Exclusion criteria :

- Ward of court or under guardianship (sheltered adults)

- Adult unable to express their consent

- Person deprived of freedom by judicial or administrative decision

- Person hospitalised without their consent

- Person under legal protection

- Existence of a previously diagnosed pathology

- Existence of a metabolic condition (obesity, diabetes) or a family history of such

- Ongoing medical treatment. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00390273
Study type Interventional
Source Centre de Recherche en Nutrition Humaine Rhone-Alpe
Contact
Status Completed
Phase Phase 1/Phase 2
Start date December 2006
Completion date October 2007

See also
  Status Clinical Trial Phase
Recruiting NCT05505396 - Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury
Completed NCT05032521 - Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study) Phase 4
Completed NCT05145049 - The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
Completed NCT03025659 - Lactate Acidosis in Postoperative Hearts
Not yet recruiting NCT04315623 - RCA for CRRT in Hyperlactatemia Patient With Increased Bleeding Risk N/A
Completed NCT04710875 - The Role of Lactate in Lipolysis and Catabolism in Humans N/A
Completed NCT03078712 - Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study N/A
Recruiting NCT03762005 - Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock N/A
Completed NCT04410315 - Hyperlactatemia During and After Tumorcraniotomy
Completed NCT02950753 - Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate? Early Phase 1
Recruiting NCT03649009 - Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients N/A
Recruiting NCT04388267 - Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic Surgery
Not yet recruiting NCT06222021 - Hyperlactacidemia in Major Abdominal Surgery and Monocarboxylate Receptors N/A
Not yet recruiting NCT04284722 - Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery Phase 4
Completed NCT00270673 - Early Lactate-Directed Therapy in the Intensive Care Unit (ICU) Phase 3
Not yet recruiting NCT05953142 - Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation. Phase 2
Not yet recruiting NCT04046861 - Influence of High Vitamin C Dose on Lactate During and After Extracorporeal Circulation N/A
Completed NCT05649358 - Pilot Testing a Novel Non-invasive Lactate Sensor N/A
Completed NCT00471614 - Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine Phase 2
Completed NCT04299815 - Lactate in the Gut N/A